Skip to main content
Figure 7 | Molecular Medicine

Figure 7

From: Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease

Figure 7

CCR2-deficient BMCs increase MCP-1 expression in APPSwe/PS1 mice. Representative dark-field photomicrographs of in situ hybridization showing the cortical expression of MCP-1 in the brains of 6-month-old APPSwe/PS1 and APPSwe/PS1/CCR2−/− mice harboring GFP or CCR2−/− BMC (A–D). MCP-1 qualitative quantification was performed for each group of mice (n = 5−12) (E). Transplantation of CCR2−/− cells caused an increase in the MCP-1 transcript levels. Brain sections were immunostained for Aβ and iba-1, and the number of plaque-associated microglia was determined in hippocampus (F) and cortex (G). APPSwe/PS1 and APPSwe/PS1/CCR2−/− harboring GFP or CCR2−/− BMC exhibited less recruitment of microglia in the plaque vicinity. Brain sections of APPSwe/PS1 (I) and APPSwe/PS1/CCR2−/− (J) mice harboring GFP-expressing cells in their bloodstream were labeled to reveal GFP cells (brown cells) together with CX3CR1 mRNA (silver grains). Results are expressed as the mean ± SEM; n = 8−16; ***P < 0.001 versus APPSwe/PS1; ##P < 0.01 and ###P < 0.001 versus APPSwe/PS1/CCR2−/−. One-way ANOVA was performed using Bonferroni or Tamhane post hoc tests. A–D: Arrowheads: MCP-1 positive signal; I and J: black arrowheads: double-labeled cells (GFP/CX3CR1 mRNA); open arrowheads: CX3CR1-positive cells (negative for GFP); red arrowheads: GFP-positive cells (negative for CX3CR1 mRNA). Scale bar 500 µm (A–D) and 50 µm (I and J). E: The plus signs correspond to the intensity and the surface of the signal. The number of the plus signs shows augment proportionally with the intensity and the surface. ■, APPSwe/PS1; , GFP → APPSwe/PS1; , CCR2−/− → APPSwe/PS1; , APPSwe/PS1/CCR2−/−; , GFP → APPSwe/PS1/CCR2−/−.

Back to article page